When tissue is damaged one reaction is the initiation of the haemostatic mechanism. This involves initially platelet interaction with the damaged vessel walls, platelet aggregation and release at the sites of damage, and subsequent local fibrin formation due to the activation of the coagulation cascade after the 'release' of various factors from the activated platelets -namely, Ca++ ions and phospholipid (PF3).
In trauma or disease in man the injury to tissue directly and indirectly can invoke a similar mechanism and, if the stimulus is very strong, the normally protective haemostatic mechanism is activated to such an extent that serious destruction of platelets and significant fibrin formation may occur both at the site of injury and also in normal tissue. In order to limit the spread of fibrin the fibrinolytic mechanism is activated along with or as a consequence of fibrin formation. This 'pathological' activation of the physiological haemostatic process has been called intravascular coagulation and fibrinolysis (ICF), a term which is considered by some to be synonymous with the diffuse intravascular coagulation syndrome (DIC). Either term has been used to define the explosive and sometimes fatal activation of the platelet/coagulation sequence as a complication of infections, malignancy, trauma, and immune complex disease in man.1 A similar sequence may also complicate abnormal events in pregnancyfor example, abruptio placentae and septic abortion. In each instance the platelet, coagulation, fibrinolysis activation is the sequel to tissue damage or the introduction into the blood of a 'trigger'.
Experimentally If the clinical presentation is analysed in relation to the above hypothesis it would seem that these patients, when the ICF/DIC syndrome is initiated by the direct 'thromboplastin trigger' alone (for instance, in obstetrics and malignancy), are more likely to have ICF alone without evidence of DIC. The changes in the blood-thrombocytopenia, fibrinogen depletion, a low level of fibrinogen, and fibrin I split products-suggest that in these syndromes only fibrin I is formed. When the indirect triggers act via their mediators (as in endotoxaemia and immune complex-disease) or 
Conclusion
The problem of intravascular coagulation and fibrinolysis continues to fascinate and puzzle. While more is being found out about its pathophysiology we cannot progress until we determine the exact pathways of activation, coagulation, and thrombin production in this condition and whether in fact it is fibrin deposition that causes the associated extensive organ malfunction.
